Stephanie Kourula (née Schulz)

Dr. Stephanie Kourula (née Schulz)

Janssen Pharmaceutica
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2014 in Nature
Verified
Journal Article
Closed access
NTNozomi Takahashi
Nozomi Takahashi
LVLars Vereecke
Lars Vereecke
MBMathieu J. M. Bertrand
Mathieu J. M. Bertrand
LDLinde Duprez
Linde Duprez
SBScott B. Berger
Scott B. Berger
PVPeter Vandenabeele
Peter Vandenabeele

25 May 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MRMaria Paula Roberti
Maria Paula Roberti
SYSatoru Yonekura
Satoru Yonekura
CDConnie P. M. Duong
Connie P. M. Duong
MPMarion Picard
Marion Picard
GFGladys Ferrere
Gladys Ferrere
LZLaurence Zitvogel
Laurence Zitvogel

1 January 2012 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
Stephanie Kourula (née Schulz)Stephanie Kourula (née Schulz)
Stephanie Kourula (née Schulz)
RWRonald Wong
Ronald Wong
HVHendrik J. Vreman
Hendrik J. Vreman
DSDavid K. Strevenson
David K. Strevenson
Metalloporphyrins are structural analogs of heme and their potential use in the management of neonatal hyperbilirubinemia has been the subject of considerable research for more than three decades. The pharmacological basis for using this class of compounds to control bilirubin levels is the targeted blockade of bilirubin production through the competitive inhibition of heme oxygenase (HO), the rate-limiting enzyme in the bilirubin production pathway. Ongoing research continues in the pursuit of identifying ideal metalloporphyrins, which are safe and effective, by defining therapeutic windows and targeted interventions for the treatment of excessive neonatal hyperbilirubinemia.

19 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPedro Saavedra
Pedro Saavedra
LHLinyan Huang
Linyan Huang
FGFarzaneh Ghazavi
Farzaneh Ghazavi
Stephanie Kourula (née Schulz)Stephanie Kourula (née Schulz)
Stephanie Kourula (née Schulz)
TBTom Vanden Berghe
Tom Vanden Berghe
MLMohamed Lamkanfi
Mohamed Lamkanfi
Clostridium difficile is the leading cause of pseudomembranous colitis in hospitalized patients. C. difficile enterotoxins TcdA and TcdB promote this inflammatory condition via a cytotoxic response on intestinal epithelial cells (IECs), but the underlying mechanisms are incompletely understood. Additionally, TcdA and TcdB engage the Pyrin inflammasome in macrophages, but whether Pyrin modulates CDI pathophysiology is unknown. Here we show that the Pyrin inflammasome is not functional in IECs and that Pyrin signaling is dispensable for CDI-associated IEC death and for in vivo pathogenesis. Instead, our studies establish that C. difficile enterotoxins induce activation of executioner caspases 3/7 via the intrinsic apoptosis pathway, and demonstrate that caspase-3/7-mediated IEC apoptosis is critical for in vivo host defense during early stages of CDI. In conclusion, our findings dismiss a critical role for inflammasomes in CDI pathogenesis, and identify IEC apoptosis as a host defense mechanism that restricts C. difficile infection in vivo.

1 July 2006 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JBJan C. Becker
Jan C. Becker
NGNina Grosser
Nina Grosser
CWChristian Waltke
Christian Waltke
Stephanie Kourula (née Schulz)Stephanie Kourula (née Schulz)
Stephanie Kourula (née Schulz)
KEKati Erdmann
Kati Erdmann
TPThorsten Pohle
Thorsten Pohle

15 April 2015 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HZHui Zhao
Hui Zhao
FKFlora Kalish
Flora Kalish
Stephanie Kourula (née Schulz)Stephanie Kourula (née Schulz)
Stephanie Kourula (née Schulz)
YYYang Yang
Yang Yang
RWRonald J. Wong
Ronald J. Wong
DSDavid K. Stevenson
David K. Stevenson
Leukocyte infiltration into the uterus is a characteristic feature in early to midpregnancy, but the composition and function of these leukocytes are not well understood. Using a pregnant murine model, we showed that myeloid cells and uterine NK (uNK) cells were the predominant populations in uteri during early to midgestation, whereas T and B cells were constrained. Uterine myeloid populations included cells that infiltrated from the circulation (myeloid-derived suppressor cells [MDSCs], monocyte-derived macrophages [Mφs], and dendritic cells [DCs]) or proliferated from resident precursors (resident Mφs [Re-Mφs] and DCs). CD11bhiLy6-Ghi cells, representing neutrophils in both blood and uterine MDSCs, significantly increased from embryonic days 8.5 to 9.5. To understand their putative functions, we used anti–Gr-1 Ab to deplete circulating neutrophils and uterine MDSCs. In the absence of MDSC suppression, uterine DCs, T cells, and regulatory T cells expanded. Conversely, uterine MDSCs responded to LPS-induced inflammation and transformed into CD14+-activated neutrophils, resulting in an upregulation of tolerogenic DCs. A high dose of LPS (2.5 μg/mouse) significantly increased the influx of neutrophils and production of proinflammatory cytokines, such as IL-1β and TNF-α, resulting in the reduction of Re-Mφs and uNK cells, and led to placental hemorrhages and fetal deaths. In summary, uterine MDSCs are important in early to midpregnancy by responding to the maternal immunologic milieu and protecting uNK cells and Re-Mφs via MDSC’s suppressive and anti-inflammatory functions. Upsetting this delicate immune balance by factors leading to either insufficient MDSCs or excessive neutrophil infiltration in the fetomaternal interface may contribute to pregnancy failure.